Skip to main content
. Author manuscript; available in PMC: 2015 Oct 28.
Published in final edited form as: Clin Lymphoma Myeloma Leuk. 2012 Nov 6;13(1):15–18. doi: 10.1016/j.clml.2012.09.009

Figure 1. PFS and OS. (A) R-CHOP for DLBCL: PFS (left) and OS (right) by AMC; (B) R-CHOP for DLBCL: PFS (left) and OS (right) by ALC; (C) R-CHOP for DLBCL: PFS (left) and OS (right) by AMLPI; (D) R-CHOP for DLBCL: PFS (left) and OS (right) by IPI.

Figure 1

Abbreviations: ALC = absolute lymphocyte count; AMC = absolute monocyte count; AMLPI = absolute monocyte and lymphocyte prognostic index; DLBCL = diffuse large B-cell lymphoma; E = number of events; IPI = international prognostic index; N = total number of patients; OS = overall survival; PFS = progression-free survival; R-CHOP = rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone.